Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 315
- 试验地点
- 5
- 主要终点
- Psychological Adjustment
研究概览
简要总结
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.
详细描述
This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed
- •Be at least 18 years old now (and at least 16 when they had their transplant)
- •Speak English
- •Have telephone service
排除标准
- 未提供
研究组 & 干预措施
Control writing type 1
干预措施: Writing C (Control informative writing) (Behavioral)
Control writing type 2
干预措施: Writing D (Control noninformative writing) (Behavioral)
Experimental Writing Type 1
干预措施: Writing A (Experimental informative writing) (Behavioral)
Experimental Writing type 2
干预措施: Writing B (Experimental noninformative writing) (Behavioral)
结局指标
主要结局
Psychological Adjustment
时间窗: At screening, baseline and 3 months following intervention
次要结局
- Quality of Life(At screening, baseline and 3 months following intervention)
